South & Central America Embolization Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Report Coverage:
  • Type (Embolization Coils, Plugs, Beads, Glues, Others)
  • Application (Neurology, Peripheral Vascular Disease, Oncology, Urology, Others)
  • End User (Hospitals, Ambulatory Centers, Others)

No. of Pages: 174
Report Code: BMIRE00032150
Category: Life Sciences
South & Central America Embolization Devices Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. South & Central America Embolization Devices Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. South & Central America Embolization Devices Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. South & Central America Embolization Devices Market Regional Analysis

6.2 South & Central America Embolization Devices Market Revenue 2021-2031 (US$ Million)
6.3 South & Central America Embolization Devices Market Forecast Analysis

7. South & Central America Embolization Devices Market Analysis – by Type

7.1 Embolization Coils
  • 7.1.1 Overview
  • 7.1.2 Embolization Coils: South & Central America Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Plugs
  • 7.2.1 Overview
  • 7.2.2 Plugs: South & Central America Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Beads
  • 7.3.1 Overview
  • 7.3.2 Beads: South & Central America Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Glues
  • 7.4.1 Overview
  • 7.4.2 Glues: South & Central America Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Others
  • 7.5.1 Overview
  • 7.5.2 Others: South & Central America Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. South & Central America Embolization Devices Market Analysis – by Application

8.1 Neurology
  • 8.1.1 Overview
  • 8.1.2 Neurology: South & Central America Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Peripheral Vascular Disease
  • 8.2.1 Overview
  • 8.2.2 Peripheral Vascular Disease: South & Central America Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Oncology
  • 8.3.1 Overview
  • 8.3.2 Oncology: South & Central America Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Urology
  • 8.4.1 Overview
  • 8.4.2 Urology: South & Central America Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Others
  • 8.5.1 Overview
  • 8.5.2 Others: South & Central America Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. South & Central America Embolization Devices Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Hospitals: South & Central America Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Ambulatory Centers
  • 9.2.1 Overview
  • 9.2.2 Ambulatory Centers: South & Central America Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Others
  • 9.3.1 Overview
  • 9.3.2 Others: South & Central America Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. South & Central America Embolization Devices Market – South and Central America Analysis

10.1 Overview

10.2 South and Central America
  • 10.2.1 South & Central America Embolization Devices Market Breakdown, by Key Country, 2025 and 2031 (%)
  • 10.2.1.1 South & Central America Embolization Devices Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 Brazil: South & Central America Embolization Devices Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.1.1 Brazil: South & Central America Embolization Devices Market Breakdown, by Type
    • 10.2.1.1.2 Brazil: South & Central America Embolization Devices Market Breakdown, by Application
    • 10.2.1.1.3 Brazil: South & Central America Embolization Devices Market Breakdown, by End User
  • 10.2.1.2 Argentina: South & Central America Embolization Devices Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.2.1 Argentina: South & Central America Embolization Devices Market Breakdown, by Type
    • 10.2.1.2.2 Argentina: South & Central America Embolization Devices Market Breakdown, by Application
    • 10.2.1.2.3 Argentina: South & Central America Embolization Devices Market Breakdown, by End User
  • 10.2.1.3 South and Central America: South & Central America Embolization Devices Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.3.1 South and Central America: South & Central America Embolization Devices Market Breakdown, by Type
    • 10.2.1.3.2 South and Central America: South & Central America Embolization Devices Market Breakdown, by Application
    • 10.2.1.3.3 South and Central America: South & Central America Embolization Devices Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Medtronic Plc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Cook Medical Holdings LLC
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Stryker Corp
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Boston Scientific Corp
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Terumo Corp
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Johnson & Johnson
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Abbott Laboratories
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 NeuroSafe Medical Co. Ltd
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Wallaby Medical
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Sirtex Medical Ltd
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 GEM srl
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
13.12 Penumbra Inc.
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments
13.13 Balt
  • 13.13.1 Key Facts
  • 13.13.2 Business Description
  • 13.13.3 Products and Services
  • 13.13.4 Financial Overview
  • 13.13.5 SWOT Analysis
  • 13.13.6 Key Developments
13.14 Lepu Medical Technology Beijing Co Ltd
  • 13.14.1 Key Facts
  • 13.14.2 Business Description
  • 13.14.3 Products and Services
  • 13.14.4 Financial Overview
  • 13.14.5 SWOT Analysis
  • 13.14.6 Key Developments
13.15 INVAMED
  • 13.15.1 Key Facts
  • 13.15.2 Business Description
  • 13.15.3 Products and Services
  • 13.15.4 Financial Overview
  • 13.15.5 SWOT Analysis
  • 13.15.6 Key Developments
13.16 Meril Life Sciences Pvt Ltd
  • 13.16.1 Key Facts
  • 13.16.2 Business Description
  • 13.16.3 Products and Services
  • 13.16.4 Financial Overview
  • 13.16.5 SWOT Analysis
  • 13.16.6 Key Developments
13.17 Merit Medical Systems Inc
  • 13.17.1 Key Facts
  • 13.17.2 Business Description
  • 13.17.3 Products and Services
  • 13.17.4 Financial Overview
  • 13.17.5 SWOT Analysis
  • 13.17.6 Key Developments
13.18 Lifetech Scientific Corp
  • 13.18.1 Key Facts
  • 13.18.2 Business Description
  • 13.18.3 Products and Services
  • 13.18.4 Financial Overview
  • 13.18.5 SWOT Analysis
  • 13.18.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - South & Central America Embolization Devices Market

  • Medtronic Plc
  • Cook Medical Holdings LLC
  • Stryker Corp
  • Boston Scientific Corp
  • Terumo Corp
  • Johnson & Johnson
  • Abbott Laboratories
  • NeuroSafe Medical Co. Ltd
  • Wallaby Medical
  • Sirtex Medical Ltd
  • GEM srl
  • Penumbra Inc.
  • Balt
  • Lepu Medical Technology Beijing Co Ltd
  • INVAMED
  • Meril Life Sciences Pvt Ltd
  • Merit Medical Systems Inc
  • Lifetech Scientific Corp
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)